COMPUGEN LTD

CGENSEC EDGAR

Biological Products, (No Diagnostic Substances)(L3)CIK: 1119774

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues	$33.5M	$7.5M	$6.0M	$2.0M	$2.0M
Cost of Revenue	$2.0M	$975.0K	$680.0K	$60.0K	$60.0K
Gross Profit	$31.5M	$6.5M	$5.3M	$1.9M	$1.9M
Research and Development Expense	$34.5M	$30.6M	$28.7M	$22.8M	$19.8M
Operating Expenses	$44.4M	$41.9M	$40.4M	$33.4M	$28.9M
Operating Income (Loss)	-$13.0M	-$35.4M	-$35.1M	-$31.5M	-$28.9M
Other Nonoperating Income (Expense)	—	—	—	—	—

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$115.0M	$121.3M	$94.2M	$132.2M	$138.3M
Assets, Current	$106.0M	$114.6M	$86.1M	$123.2M	$129.1M
Cash and Cash Equivalents, at Carrying Value	$13.9M	$11.1M	$7.8M	$7.1M	$9.2M
Accounts Receivable, after Allowance for Credit Loss, Current	—	—	—	—	$2.0M
Liabilities, Current	$20.2M	$26.3M	$11.9M	$17.1M	$10.5M
Accounts Payable, Current	$1.8M	$3.5M	$1.8M	$4.6M	$1.4M
Stockholders' Equity Attributable to Parent	$77.7M	$106.7M	$119.8M	$38.3M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$35.9M	-$34.1M	-$22.7M	-$28.3M	-$27.9M
Net Cash Provided by (Used in) Investing Activities	$35.5M	$37.1M	$6.6M	-$82.2M	$5.3M
Net Cash Provided by (Used in) Financing Activities	$3.1M	$353.0K	$16.8M	$108.5M	$25.9M
Payments to Acquire Property, Plant, and Equipment	$172.0K	$477.0K	$292.0K	$166.0K	$155.0K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)